Forbion Capital Partners

Summary

Forbion Capital Partners is the famous VC, which was founded in 2007. The company was established in Europe in The Netherlands. The leading representative office of defined VC is situated in the Naarden.

The fund has specific favorite in a number of founders of portfolio startups. If startup sums 3 or 4 of the founder, the chance for it to be financed is low. Moreover, a startup needs to be at the age of 6-10 years to get the investment from the fund. Among the various public portfolio startups of the fund, we may underline AM Pharma, Mitralign, BioVex Among the most popular fund investment industries, there are Clinical Trials, Health Diagnostics. For fund there is no match between the location of its establishment and the land of its numerous investments - United States.

The usual cause for the fund is to invest in rounds with 4-5 partakers. Despite the Forbion Capital Partners, startups are often financed by Oxford Bioscience Partners, Giza Venture Capital, ABN AMRO Fund. The meaningful sponsors for the fund in investment in the same round are Oxford Bioscience Partners, New Science Ventures, Andera Partners. In the next rounds fund is usually obtained by Takeda Ventures, Oxford Bioscience Partners, NGN Capital.

The higher amount of exits for fund were in 2015. Speaking about the real fund results, this VC is 14 percentage points more often commits exit comparing to other organizations. The fund is constantly included in 2-6 investment rounds annually. Opposing the other organizations, this Forbion Capital Partners works on 10 percentage points more the average amount of lead investments. The average startup value when the investment from Forbion Capital Partners is 50-100 millions dollars. Deals in the range of 10 - 50 millions dollars are the general things for fund. The important activity for fund was in 2011. Despite it in 2019 the fund had an activity.

Besides them, we counted 10 critical employees of this fund in our database.